Shopping Cart
- Remove All
- Your shopping cart is currently empty
PROTAC IDO1 Degrader-1, a pioneering compound, efficiently targets indoleamine 2,3-dioxygenase 1 (IDO1) for ubiquitination and degradation by recruiting IDO1 to the CRBN E3 ligase, thereby facilitating its entry into the ubiquitin-proteasome system (UPS) with a DC50 of 2.84 μM. This compound also moderately enhances the tumor-killing efficacy of HER2 CAR-T cells[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $697 | Backorder |
Description | PROTAC IDO1 Degrader-1, a pioneering compound, efficiently targets indoleamine 2,3-dioxygenase 1 (IDO1) for ubiquitination and degradation by recruiting IDO1 to the CRBN E3 ligase, thereby facilitating its entry into the ubiquitin-proteasome system (UPS) with a DC50 of 2.84 μM. This compound also moderately enhances the tumor-killing efficacy of HER2 CAR-T cells[1]. |
Targets&IC50 | IDO1:1.07 μM (IC50), IDO1:2.84 μM (DC50) |
In vitro | PROTAC IDO1 Degrader-1 (compound 2c) (10 μM; 24 hours) notably decreases IDO1 levels induced by IFN-γ [1]. When combined with IFN-γ (5 ng/mL) and incubated with HeLa cells for 24 hours, significant dose-dependent degradation is observed. PROTAC IDO1 Degrader-1, in combination with chimeric antigen receptor-modified T (CAR-T) cells, enhances the tumor-killing activity of HER-2 CAR-T cells [1]. It induces significant and persistent degradation of IDO1 with a maximum degradation (dmax) of 93% in HeLa cells [1]. |
Alias | PROTAC IDO1 Degrader-1 |
Molecular Weight | 966.816 |
Formula | C40H53BrFN9O13 |
Cas No. | 2488851-89-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.